USA - NASDAQ:EXPO - US30214U1025 - Common Stock
The current stock price of EXPO is 68.76 USD. In the past month the price decreased by -1.66%. In the past year, price decreased by -29.87%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VRSK | VERISK ANALYTICS INC | 32.13 | 31.15B | ||
| EFX | EQUIFAX INC | 26.6 | 25.32B | ||
| LDOS | LEIDOS HOLDINGS INC | 16.3 | 24.26B | ||
| J | JACOBS SOLUTIONS INC | 26.22 | 18.02B | ||
| ULS | UL SOLUTIONS INC - CLASS A | 50.28 | 17.57B | ||
| TRU | TRANSUNION | 19.09 | 15.62B | ||
| CACI | CACI INTERNATIONAL INC -CL A | 21.77 | 13.13B | ||
| BAH | BOOZ ALLEN HAMILTON HOLDINGS | 13.21 | 9.98B | ||
| PSN | PARSONS CORP | 25.82 | 8.82B | ||
| AMTM | AMENTUM HOLDINGS INC | 10.53 | 5.30B | ||
| KBR | KBR INC | 10.68 | 5.26B | ||
| FCN | FTI CONSULTING INC | 18.81 | 5.22B |
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,168 full-time employees. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. The company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
EXPONENT INC
149 Commonwealth Drive
Menlo Park CALIFORNIA 94025 US
CEO: Catherine Ford Corrigan
Employees: 1168
Phone: 16503269400
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,168 full-time employees. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. The company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
The current stock price of EXPO is 68.76 USD. The price decreased by -0.19% in the last trading session.
EXPONENT INC (EXPO) has a dividend yield of 1.72%. The yearly dividend amount is currently 1.07.
EXPO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
9 analysts have analysed EXPO and the average price target is 89.76 USD. This implies a price increase of 30.54% is expected in the next year compared to the current price of 68.76.
The next ex-dividend date for EXPONENT INC (EXPO) is December 5, 2025.
EXPONENT INC (EXPO) currently has 1168 employees.
ChartMill assigns a fundamental rating of 6 / 10 to EXPO. EXPO has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months EXPO reported a non-GAAP Earnings per Share(EPS) of 2.05. The EPS decreased by -0.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.35% | ||
| ROA | 13.54% | ||
| ROE | 24.04% | ||
| Debt/Equity | 0 |
9 analysts have analysed EXPO and the average price target is 89.76 USD. This implies a price increase of 30.54% is expected in the next year compared to the current price of 68.76.
For the next year, analysts expect an EPS growth of -1.05% and a revenue growth 4.08% for EXPO